Pharmafile Logo
Pharmafocus logo
Advanced Search

You have 6 new messages

March 26, 2007
Medical Communications, Sales and Marketing e-marketing, marketing, marketing mix, new media

What are the biggest challenges in 2007 for e-marketing?Overexposure of e-detailing gave a poor response in many cases in 2006 …

Feature

Diabetes UK report criticises cutbacks in NHS

March 23, 2007
diabetes

In a new report, Diabetes UK has criticised cutbacks in NHS diabetes treatment, suggesting that service reductions are putting patients' …

News

Eisai to buy biotech Morphotek

March 23, 2007
Sales and Marketing Eisai, biotech

Eisai is to acquire Morphotek for $325 million, making it the latest pharma company to buy outright a biotech company …

News

AstraZeneca’s pipeline suffers another blow

March 23, 2007
Research and Development

AstraZeneca seems likely to abandon another of its drug projects in what is the latest major late-stage failure to have …

News

European News Roundup

March 23, 2007
Sales and Marketing

Datamonitor reports on the European market:Lilly withdraws EU Arxxant applicationEli Lilly has withdrawn a marketing application for diabetic retinopathy drug …

News

US News Roundup

March 23, 2007
Sales and Marketing

Datamonitor reports on the American market:FDA grants Ranbaxy tentative approval for insomnia drugRanbaxy has  received tentative approval from the FDA …

News

Schering acquisition boosts Bayer’s 2006 turnover figures

March 22, 2007
Sales and Marketing

Bayer HealthCare's turnover rose 46% to €11.7 billion on the back of Bayer Group's acquisition of Schering last year. As …

News

Shire to raise Alzheimer’s awareness

March 21, 2007
Medical Communications

Shire Pharmaceuticals has appointed PR and med ed firm hsdcommunications to help raise awareness of its Alzheimer's treatment Reminyl.The specialty …

News

BMS expands Indian biotech collaboration

March 21, 2007
Research and Development BMS, India

Bristol-Myers Squibb will establish a new integrated drug development facility in Bangalore as part of an expansion of its R&D …

News

Servier “named and shamed” for sales slides

March 21, 2007
Sales and Marketing ethics

Servier has been publicly "named and shamed" for using inappropriate materials to train its sales reps.Servier and another company, Shire …

News

Schering-Plough to buy Organon for 11 billion euros

March 21, 2007
Sales and Marketing Merck, Schering-Plough

Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …

News

Abbott withdraws HIV drugs from Thailand after patent row

March 21, 2007
Sales and Marketing HIV

Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …

News

E-marketing has arrived…but not everyone has noticed

March 19, 2007
Medical Communications, Sales and Marketing e-marketing, marketing, new media

Feature

Tyverb gains first approval in US

March 14, 2007
Sales and Marketing breast cancer

GlaxoSmithKline's breast cancer drug, Tyverb, has been approved in the US and could help women who have failed to respond …

News

New diabetes drug launched in UK

March 14, 2007
Sales and Marketing Byetta, diabetes

A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …

News

Pharmafocus Europe

March 12, 2007
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus

Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …

Feature

Shire dispels doubts about New River acquisition

March 12, 2007
Sales and Marketing

Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …

News

Making your mark in 100 days

March 12, 2007
Business Services management, recruitment

Congratulatons, you've got the job – you're a senior executive – maybe even the chief executive officer. It's the opportunity …

Feature

NICE judges Tarceva too expensive for NHS

March 9, 2007
Sales and Marketing Tarceva, lung cancer

Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …

News

Huntsworth makes US acquisition

March 9, 2007
Medical Communications

Communications group Huntsworth Health has acquired US agency Dorland Global Corporation, extending its reach into the world's largest pharmaceutical market.Dorland …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026